Summary
INGN Chart
Here's Why You Should Add Inogen Stock to Your Portfolio Now
INGN gains momentum from rising POC demand, new product launches and strong Q3 sales, even as competition and forex swings temper near-term growth.
Down 19.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Inogen (INGN)
Inogen (INGN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Slow Progress At Inogen
Inogen (INGN) continues its turnaround, showing progress in revenue growth and margins, but the pace remains slower and riskier than the market desires. INGN posted positive adjusted EBITDA and raised full-year guidance, despite mixed quarterly results and ongoing volatility in direct-to-consumer and rental segments. The company's strong market position, new product launches, and partnerships offer long-term growth potential, especially as patients consistently prefer portable solutions.
Inogen Inc. (INGN) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Inogen Inc. ever had a stock split?
Inogen Inc. Profile
| - Industry | - Sector | Kevin R. M. Smith CEO | NASDAQ (NGS) Exchange | 45780L104 CUSIP |
| US Country | 766 Employees | - Last Dividend | - Last Split | 14 Feb 2014 IPO Date |
Overview
Inogen, Inc. is a leading medical technology company that focuses on the development, manufacturing, and commercialization of portable oxygen concentrators. These devices are essential for patients who require supplemental long-term oxygen therapy, catering to those suffering from chronic respiratory conditions. The company's mission is to improve the quality of life for its users by offering innovative solutions that promote mobility and independence. Inogen has established a strong market presence both in the United States and internationally, serving patients, physicians, other clinicians, and third-party payors. Founded in 2001, Inogen has its headquarters in Goleta, California, from where it continues to expand its reach and impact in the medical technology space.
Products and Services
- Inogen One: This is Inogen's flagship portable oxygen concentrator, designed to enhance the mobility of patients while providing a reliable source of supplemental oxygen. By concentrating the air around the patient, the Inogen One device ensures that users have a continuous oxygen supply, supporting their respiratory needs without compromising their lifestyle.
- Inogen At Home: Recognizing the need for a stationary solution for home use, Inogen also offers the Inogen At Home oxygen concentrator. This device is engineered for efficiency and convenience, providing high-quality oxygen therapy with minimal noise and power usage, making it an ideal companion for patients at home.
- Simeox: Simeox is a technologically advanced airway clearance device offered by Inogen. It aims to assist patients with mucus clearance, enhancing their pulmonary function. This device is especially useful for individuals with conditions that lead to increased mucus production, facilitating easier breathing.
- Batteries and Accessories: In addition to the main oxygen concentrator units, Inogen provides a range of batteries and accessories to support and enhance the functionality of its products. This includes batteries for extended mobility, carrying cases, and other accessories designed to improve the user experience.
- Rental Services: Understanding that purchasing might not be the best option for all, Inogen offers rental services for its products. This allows patients to access the benefits of Inogen's oxygen concentrators without the upfront cost, providing flexibility and ease of use.
Contact Information
